CS Pharmaceuticals
PrivateLast Round
Corporate Funding
Nov 22, 2021
Total Funding Raised
$4.96M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
CS Pharmaceuticals operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Corporate Funding round in November 2021.
CS Pharmaceuticals is a pharmaceuticals company that develops and commercialises innovative ophthalmology, rare and speciality disease products to address high unmet medical needs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CS Pharmaceuticals Comparables
Compare CS Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sperogenix Therapeutics | 79% | |
| Arctic Vision | 71% | |
| Hasten Biopharmaceutical Co., Ltd. | 66% |
For institutional investors. Book with your work email.
CS Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Nov 22, 2021 | ||||
| Seed | Jun 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CS Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Downing Ventures | Corporate Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 368% MoM, from 235 to 1.1K.
- May 17, 2026
Monthly visitors increased 36% MoM, from 803 to 1.1K.
For institutional investors. Book with your work email.
CS Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CS Pharmaceuticals's valuation, stock price, and market status.
Is CS Pharmaceuticals a public or private company?
CS Pharmaceuticals is a private company.
What is the current stock price of CS Pharmaceuticals?
CS Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks CS Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CS Pharmaceuticals worth (valuation)?
Valuation information for CS Pharmaceuticals is not publicly available.
Can I buy CS Pharmaceuticals stock?
CS Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CS Pharmaceuticals's last funding round?
CS Pharmaceuticals's most recent funding round was Corporate Funding on November 22, 2021.
Who are the main investors in CS Pharmaceuticals?
Key investors in CS Pharmaceuticals include Downing Ventures.
Will CS Pharmaceuticals IPO soon?
No public IPO plans have been announced for CS Pharmaceuticals.
How can I track CS Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in CS Pharmaceuticals's shares on secondary markets.